OIS Podcast Ep #397: Todays Therapies are Not Sufficient: A Marketplace Ripe for Innovation

OIS Podcast Ep #396: AI and Robotics Transforming Retina Medicine

OIS Podcast Ep #395: Exploring the FDA

OIS Podcast Ep #394: Empathy in Action

OIS Podcast Ep #393: From Ophthalmology Clinics to Business Leadership

OIS Podcast Ep #392: Exploring the Future of Eye Care

OIS Podcast Ep #391: 5 Mistakes To Avoid In Biotech Investor Pitch Decks

OIS Podcast Ep #390: Unlocking the Future of Presbyopia Treatment

Re-Vana Therapeutics | Patrick Ruane, PhD, Chief Operating Officer

Sydnexis | Nick Ruth, Chief Commercial Officer

EyeLight Innovations | Michael Berlin, MD, Founder & CMO

Reverse Pitch by Strategics

OIS XIII Innovator Award 2023

A View from the Street

Vantage Biosciences | Graeme Martin, PhD

Belite Bio | Nathan Mata, PhD, Chief Scientific Officer

Ocuphire | George Magrath, MD, CEO

Rezolute Bio | Raj Agrawal, MD, Vice President for Clinical Development and Ophthalmology Lead

Oculis | Riad Sherif, MD, CEO

ONL Therapeutics | David Esposito, President & CEO

Stuart Therapeutics - Eric Schlumpf, CEO - Spotlight on Platform Innovation

Future of Retina Innovation

Nanoscope Therapeutics | Jared Stephens, VP, Strategy & Business Development

InGel Therapeutics | Pierre Dromel, PhD, Founder & CEO

Ray Therapeutics | Peter Francis, MD, PhD, Chief Medical & Scientific Officer

Opus Genetics | Ben Yerxa, PhD, CEO

Stealth Biotherapeutics | Reenie McCarthey, CEO

Tarsier Pharma | Daphne Haim-Langford, PhD, CEO

Annexon Biosciences | Douglas Love, President & CEO

Ocular Therapeutix | Christopher White, Chief Business Officer